articleTop 1% cited
Long-term Results of Riboflavin Ultraviolet A Corneal Collagen Cross-linking for Keratoconus in Italy: The Siena Eye Cross Study
American Journal of Ophthalmology · 2010 · Vol. 149(4) · pp. 585–593
Aldo Caporossi(Ospedale Santa Maria alle Scotte)Cosimo Mazzotta✉(Ospedale Santa Maria alle Scotte)Stefano Baiocchi(Ospedale Santa Maria alle Scotte)Tomaso Caporossi(Agostino Gemelli University Polyclinic)
Corneal surgery and disordersCorneal Surgery and TreatmentsOcular Surface and Contact LensKeratoconusCorneal collagen cross-linkingOphthalmologyRiboflavinMedicineOptometryUltraviolet aTerm (time)CorneaDermatology
MeSH terms
AdolescentAdultCell CountChildCollagenCorneal StromaEndothelium, CornealFemaleFollow-Up StudiesHumansItalyKeratoconusMalePhotochemotherapyPrognosis
Citations
683
FWCI
36.32
field-weighted impact
References
27
Percentile
100%
vs. same field & year
Citations per year
Cited by
A Randomized, Controlled Trial of Corneal Collagen Cross-Linking in Progressive Keratoconus
Ophthalmology · 2014 · 690 citations
References
Central corneal endothelial cell changes over a ten-year period.
American Journal of Ophthalmology · 1997 · 584 citations
Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconus
American Journal of Ophthalmology · 2003 · 2,905 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.